Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Avoid Pod Point Group Holdings (PODP) by Steve Moore in ShareProphets
- Buy Tharisa (DI) (THS) by Hot Stock Rockets in ShareProphets
- Avoid Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Avoid Zenova Group (ZED) by Steve Moore in ShareProphets
- Hold Team17 Group (TM17) by Jefferies
- Hold BP (BP.) by Mark David Hartley in The Motley Fool
- Buy Intertek Group (ITRK) by Redburn Partners
- Buy IQE (IQE) by Numis
- Hold 888 Holdings (DI) (888) by Numis
- Buy Oxford Metrics (OMG) by Numis
- Buy Hunting (HTG) by Kepler Cheuvreux
- Add Man Group (EMG) by Numis
- Buy NATWEST GROUP (NWG) by Peel Hunt
- Overweight VinaCapital Vietnam Opportunity Fund Ltd. (VOF) by Barclays
- Hold Lloyds Banking Group (LLOY) by Peel Hunt
- Overweight Victrex plc (VCT) by Barclays
- Buy Barclays (BARC) by Peel Hunt
- Equal Weight Johnson Matthey (JMAT) by Barclays
Synairgen (SNG) Share Price
Health Care Sector
NOTE: This is based on 28 open tips for Synairgen (SNG)
| Latest Bid : 6.02p | Latest Ask : 7.48p |
| High Today : 8.00p | Low Today : 6.30p |
| This Years High : 14.00p | This Years Low : 4.88p |
| Volume : 289,535 | MKT Cap : £13.57M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Synairgen (SNG) Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.Synairgen (SNG) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Richard Evans | Premium Only | 2021-01-21 10:25:00 21/01/2021 | -10.92% |
| Sell | Richard Evans | Premium Only | 2021-01-20 09:20:00 20/01/2021 | -3.91% |
| Buy | Nadia Yaqub | Premium Only | 2021-01-19 13:30:00 19/01/2021 | -96.26% |
| Buy | Nadia Yaqub | Premium Only | 2020-12-31 11:35:00 31/12/2020 | -96.14% |
| Buy | Peter Brailey | Premium Only | 2020-12-25 12:25:00 25/12/2020 | -95.44% |
Synairgen (SNG) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 6.02p | Latest Ask : 7.48p |
| High Today : 8.00p | Low Today : 6.30p |
| This Years High : 14.00p | This Years Low : 4.88p |
| Volume : 289,535 | MKT Cap : £13.57M |
Synairgen Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Synairgen Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Richard Evans | Premium Only | 2021-01-21 10:25:00 21/01/2021 | -10.92% |
| Sell | Richard Evans | Premium Only | 2021-01-20 09:20:00 20/01/2021 | -3.91% |
| Buy | Nadia Yaqub | Premium Only | 2021-01-19 13:30:00 19/01/2021 | -96.26% |
| Buy | Nadia Yaqub | Premium Only | 2020-12-31 11:35:00 31/12/2020 | -96.14% |
| Buy | Peter Brailey | Premium Only | 2020-12-25 12:25:00 25/12/2020 | -95.44% |